Everything You Need To Know About Brain Ischemia Industry 2021

 Brain ischemia refers to the insufficient supply of blood to the brain. Due to inadequate supply of blood, the brain is unable to perform its metabolic activities. Moreover, the poor supply of oxygen to brain cells leads to ischemic stroke or cerebral infarction. Vision impairment, blindness, weakness in body, and difficulties in co-ordination are some of the symptoms represented by brain ischemia.

Get Sample PDF 

The brain ischemia market is expected to witness considerable growth due to significant prevalence of the brain ischemia. Moreover, strong pipeline candidates are also estimated to offer lucrative environment for the market growth. However, stringent government regulations and lack of proper infrastructur are expected to hamper the growth of the global brain ischemia market.

Brain Ischemia Market is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 606.73 million in 2018 and is projected to register a 6.57% CAGR over the forecast period.

Brain ischemia occurs when there is insufficient blood flow to the brain to meet the metabolic demand. This condition leads to poor oxygen supply or cerebral hypoxia and hence leading to the death of the brain tissues or brain ischemia.

Factors such as the increasing burden of ischemic strokes and growth in the geriatric population which is prone to brain ischemia are expected to drive the market growth. According to a survey carried out by the World Health Organization (WHO) in 2019, ischemic stroke is the third most cause of death in the adult population. Moreover, the rising focus of companies for developing drugs for the treatment of brain ischemia is also expected to boost market growth.